Xingyu Mu

769 total citations
29 papers, 560 citations indexed

About

Xingyu Mu is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Xingyu Mu has authored 29 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Surgery. Recurrent topics in Xingyu Mu's work include Cancer Immunotherapy and Biomarkers (6 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Renal cell carcinoma treatment (4 papers). Xingyu Mu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Renal cell carcinoma treatment (4 papers). Xingyu Mu collaborates with scholars based in China, United States and Greece. Xingyu Mu's co-authors include Mingyue Tan, Le Tao, Ke Wu, Zhihong Liu, Jie Fan, Shuangqing Li, Zhihua Zhou, Zhong Zheng, Yuyang Zhao and Ming Cao and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Xingyu Mu

28 papers receiving 553 citations

Peers

Xingyu Mu
Johann Gout Germany
Xiaojun Zheng China
Qiang Sun China
Yugang Cheng China
Eyal J. Scheinman Israel
Kirsty R. Greenow United Kingdom
Ran Rostoker Israel
Zhaohua Gao China
Haiyan Pan China
Marília M. Dias Brazil
Johann Gout Germany
Xingyu Mu
Citations per year, relative to Xingyu Mu Xingyu Mu (= 1×) peers Johann Gout

Countries citing papers authored by Xingyu Mu

Since Specialization
Citations

This map shows the geographic impact of Xingyu Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingyu Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingyu Mu more than expected).

Fields of papers citing papers by Xingyu Mu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingyu Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingyu Mu. The network helps show where Xingyu Mu may publish in the future.

Co-authorship network of co-authors of Xingyu Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Xingyu Mu. A scholar is included among the top collaborators of Xingyu Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingyu Mu. Xingyu Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Chenyu, et al.. (2025). TsRNA-49–73-Glu-CTC: A promising serum biomarker in non-small cell lung cancer. PLoS ONE. 20(3). e0320187–e0320187. 2 indexed citations
2.
Ma, Yuehua, et al.. (2025). Impact of COPD and sarcopenia on all-cause and respiratory mortality in US adults: NHANES 1999–2018. BMC Pulmonary Medicine. 25(1). 223–223. 2 indexed citations
3.
Mu, Xingyu, et al.. (2024). Lignite degraded by Trichoderma citrinoviride: Products, processes and mechanisms. International Biodeterioration & Biodegradation. 197. 105957–105957. 1 indexed citations
4.
5.
Zhang, Zengqiang, Meitong Li, Xin Feng, et al.. (2024). Microbial transformation of lignite into methane: Insights from anaerobic-activated sludge systems. Bioresource Technology Reports. 28. 101970–101970. 2 indexed citations
6.
Wu, Ke, Weiguang Zhao, Zhixian Yao, et al.. (2023). The microbiota and renal cell carcinoma. Cellular Oncology. 47(2). 397–413. 11 indexed citations
7.
Mu, Xingyu, et al.. (2023). Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: a systematic review and meta-analysis. Frontiers in Endocrinology. 14. 1214334–1214334. 35 indexed citations
8.
Mu, Xingyu, Jiao Xu, Ya Luo, et al.. (2022). A Case Report of Leukocytosis During Modified Electroconvulsive Therapy of Paranoid Personality Disorder. Frontiers in Psychiatry. 13. 899847–899847.
9.
Yao, Zhixian, Zhong Zheng, Weiguang Zhao, et al.. (2022). Comprehensive Characterization of Metabolism‐Associated Subtypes of Renal Cell Carcinoma to Aid Clinical Therapy. Oxidative Medicine and Cellular Longevity. 2022(1). 9039732–9039732. 4 indexed citations
10.
Mu, Xingyu, et al.. (2022). [Effect of Social Support on Multimorbidity and Related Outcomes of Middle-Aged and Older Adults in China].. PubMed. 53(5). 872–879. 1 indexed citations
11.
Zhang, Encheng, Siteng Chen, Fei Cheng, et al.. (2021). CDK1/FBXW7 facilitates degradation and ubiquitination of MLST8 to inhibit progression of renal cell carcinoma. Cancer Science. 113(1). 91–108. 9 indexed citations
12.
Zheng, Zhong, Weiguang Zhao, Feng Sun, et al.. (2021). IL‐6 Promotes the Proliferation and Immunosuppressive Function of Myeloid‐Derived Suppressor Cells via the MAPK Signaling Pathway in Bladder Cancer. BioMed Research International. 2021(1). 5535578–5535578. 21 indexed citations
13.
Xu, Jiao, Dong Zhang, Xingyu Mu, et al.. (2021). Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology. 12. 769069–769069. 40 indexed citations
14.
15.
Zheng, Zhong, Ke Wu, Xingyu Mu, et al.. (2020). Hyperprogressive disease in patients with advanced renal cell carcinoma: a new pattern of post-treatment cancer behavior. Immunologic Research. 68(4). 204–212. 4 indexed citations
16.
Zheng, Zhong, Ke Wu, Xingyu Mu, et al.. (2019). Prognostic nomogram for bladder cancer with brain metastases: a National Cancer Database analysis. Journal of Translational Medicine. 17(1). 411–411. 21 indexed citations
17.
Wu, Ke, Mingyue Tan, Juntao Jiang, et al.. (2018). Cisplatin inhibits the progression of bladder cancer by selectively depleting G-MDSCs: A novel chemoimmunomodulating strategy. Clinical Immunology. 193. 60–69. 39 indexed citations
18.
Mu, Xingyu, et al.. (2018). Self-retaining barbed suture reduces warm ischemia time during laparoscopic partial nephrectomy. Minimally Invasive Therapy & Allied Technologies. 27(5). 272–277. 10 indexed citations
19.
Tan, Mingyue, Xingyu Mu, Zhihong Liu, et al.. (2017). microRNA-495 promotes bladder cancer cell growth and invasion by targeting phosphatase and tensin homolog. Biochemical and Biophysical Research Communications. 483(2). 867–873. 38 indexed citations
20.
Tan, Mingyue, Xingyu Mu, Bin Liu, et al.. (2013). SUMO-Specific Protease 2 Suppresses Cell Migration and Invasion through Inhibiting the Expression of MMP13 in Bladder Cancer Cells. Cellular Physiology and Biochemistry. 32(3). 542–548. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johann Gout Breakdown of academic impact, for papers by Xiaojun Zheng Breakdown of academic impact, for papers by Qiang Sun Breakdown of academic impact, for papers by Yugang Cheng Breakdown of academic impact, for papers by Eyal J. Scheinman Breakdown of academic impact, for papers by Kirsty R. Greenow Breakdown of academic impact, for papers by Ran Rostoker Breakdown of academic impact, for papers by Zhaohua Gao Breakdown of academic impact, for papers by Haiyan Pan Breakdown of academic impact, for papers by Marília M. Dias
Rankless by CCL
2026